剖宫产瘢痕妊娠治疗现状及进展  

Current Situation and Advance in the Treatment of Cesarean Scar Pregnancy

作　　者：吴映云[1] 邵华江[1] 马建婷[1] 

机构地区：[1]宁波大学医学院,宁波315211

出　　处：《生殖与避孕》2014年第5期395-400,共6页Reproduction and Contraception

基　　金：浙江省医药卫生科技计划项目;项目号:2012KYBl90

摘　　要：近年来对剖宫产瘢痕妊娠(CSP)的报道逐渐增多,也随之出现了各种不同的治疗方法,但在全球范围内仍无统一的治疗方案。药物治疗主要为甲氨蝶呤(MTX)的全身、局部及联合用药;介入治疗大大降低了常规治疗切除子宫的风险,是目前CSP患者大出血的首选止血措施;手术治疗主要包括清宫术、多种途径病灶切除的保守性手术及子宫切除术。虽然CSP的治疗方法已达31种之多,但仍然处于小样本研究,治疗方案的选择应遵循适合个体病情特点的个体化治疗原则。In recent years, the amount of reports related to cesarean scar pregnancy （CSP） is growing gradually, and at the same time a variety of different treatment methods have been proposed. However, within the global scope, there is still no universal treatment option for the management of CSP. Methotrexate （MTX）-based drug treatment includes systemic therapy, local therapy and combination therapy. As the interventional therapy avoids the risk of hysterectomy in conventional conservative treatments, it is the most used haemostatic way for hemorrhage of CSP patients. Surgical treatments comprise suction curettage, conservative operation of lesion resection in multiple ways and hysterectomy. Although there are as many as 31 CSP therapies, they are still at the stage of small sample research. The selection of treatment should follow the principle of individual therapy according to the patient＇s condition.

关 键 词：剖宫产瘢痕妊娠 治疗 进展 

分 类 号：R714.22[医药卫生—妇产科学]